[Conference presentation] Presenting the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD™ 2026)

Sysmex Corporation presented the latest data on the development of blood-based biomarkers for Alzheimer's Disease at the International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD™ 2026) held from March 17^th to 21^st, 2026 in Copenhagen, Denmark.

[Poster presentation]

Session	Subject	Presenter (Affiliation)
Theme A: β-Amyloid Diseases SHIFT 01-454^*1	Development of a fully automated plasma p-Tau205 immunoassay demonstrating high concordance with an immunoprecipitation mass spectrometry assay Overview of presentation	Kengo Ishiki (Sysmex corporation)
Theme A: β-Amyloid Diseases SHIFT 02-412^*2	Development of predictive models for amyloid positivity using routine health check-up items in older Japanese adults Overview of presentation	Shun Murakami (Sysmex corporation)
Theme A: β-Amyloid Diseases SHIFT 02-365^*3	Blood-based prediction of CSF amyloid pathology using plasma p-Tau217 and p-Tau217/Aβ42 ratio in the SPIN cohort Overview of presentation	Yuko Mori (Sysmex R&D Center Europe GmbH)

Session

Subject

Presenter
(Affiliation)

Theme A: β-Amyloid Diseases
SHIFT 01-454^*1

Development of a fully automated plasma p-Tau205 immunoassay demonstrating
high concordance with an immunoprecipitation mass spectrometry assay

Overview of presentation

Kengo Ishiki
(Sysmex corporation)

Theme A: β-Amyloid Diseases
SHIFT 02-412^*2

Development of predictive models for amyloid positivity using
routine health check-up items in older Japanese adults

Overview of presentation

Shun Murakami
(Sysmex corporation)

Theme A: β-Amyloid Diseases
SHIFT 02-365^*3

Blood-based prediction of CSF amyloid pathology using plasma p-Tau217 and
p-Tau217/Aβ42 ratio in the SPIN cohort

Overview of presentation

Yuko Mori
(Sysmex R&D Center Europe GmbH)

[Poster Presentation by Prof. Charlotte Teunissen, Amsterdam UMC]

Session	Subject
Theme A: β-Amyloid Diseases SHIFT 02-431^*4	High diagnostic performance of the random-access HISCL p-Tau217, Aβ42 and Aβ40 plasma assays in detecting amyloid pathology across clinical stages Overview of presentation

Session

Subject

Theme A: β-Amyloid Diseases
SHIFT 02-431^*4

High diagnostic performance of the random-access HISCL p-Tau217, Aβ42 and Aβ40 plasma assays in detecting
amyloid pathology across clinical stages

Overview of presentation

Terminology
*1 Co-presentation with Eisai Co., Ltd.
*2 Co-presentation with Hirosaki University
*3 Co-presentation with Hospital de la Santa Creu i Sant Pau, Spain
*4 Co-presentation with Amsterdam UMC

Information contained in the news and event is current as of the date of the announcement,
but may be subject to change without prior notice.

Back to "News / Event"